Table II.

Blood pressure (mm Hg) and heart rate (bpm) of each patient during the observation period (weeks −8 to 0) and the efonidipine treatment period (weeks 0 to 12).

	Study Week
	−8			−4			0			4			8			12
Patient No.	SBP	DBP	HR	SBP	DBP	HR	SBP	DBP	HR	SBP	DBP	HR	SBP	DBP	HR	SBP	DBP	HR
1	141	67	93	103	59	91	137	70	91	141	83	85	141	73	88	166	75	78
2	135	95	92	120	101	86	122	87	100	154	103	90	128	92	88	144	103	97
3	–	–	–	114	76	88	130	85	87	–	–	–	123	85	80	–	–	–
4	148	89	81	136	81	88	136	84	87	127	86	72	149	96	74	149	84	72
5	135	85	101	137	83	96	146	88	103	148	96	82	145	96	90	164	95	71
6	117	77	108	122	81	96	132	84	93	125	92	94	130	91	88	–	–	–
7	133	86	105	139	98	119	128	97	111	123	94	88	–	–	–	–	–	–
8	116	63	93	118	99	92	121	75	95	106	66	82	131	87	84	88	72	80
9	–	–	–	116	83	91	108	71	102	135	89	93	113	79	97	146	97	103
10	–	–	–	149	93	96	155	77	87	–	–	–	142	66	83	143	73	91
11	142	89	81	139	91	88	141	91	93	128	91	92	148	95	101	–	–	–
12	147	95	91	133	94	89	153	105	97	151	111	99	151	89	66	139	84	94
13	135	96	83	121	86	104	–	–	–	146	91	85	–	–	–	–	–	–
14	145	82	89	116	80	100	134	79	92	149	87	92	154	80	86	159	88	76
15	156	80	107	174	100	96	141	86	107	140	84	94	146	77	91	130	76	90
16	142	78	88	160	75	85	150	79	83	164	81	83	147	61	89	124	64	87
17	143	84	91	166	98	113	147	82	91	159	73	89	123	63	93	132	69	103
18	135	84	70	119	88	80	144	85	92	146	101	74	144	79	79	142	95	76

SBP = systolic blood pressure (normal value, ≤140 mm Hg); DBP = diastolic blood pressure (normal value, ≤90 mm Hg); HR = heart rate (normal value, ≤70 bpm).